New drug trial offers hope for Tough-to-Treat brain tumors
NCT ID NCT07428616
Summary
This study is testing whether an experimental drug called zanzalintinib can help control recurrent meningioma brain tumors that have continued growing despite standard treatments like surgery and radiation. The trial will enroll 100 adults whose tumors have returned or progressed, measuring whether the drug shrinks tumors and how long it keeps the cancer from worsening. Researchers will also closely monitor side effects and quality of life during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.